Trump administration’s marijuana rescheduling step opens a fresh policy fight
The federal government took a narrow marijuana step on April 23 and kicked the bigger fight down the road. The Justice Department and DEA said they were immediately placing FDA-approved products containing marijuana, along with marijuana products covered by qualifying state medical licenses, in Schedule III of the Controlled Substances Act. At the same time, they opened an expedited administrative hearing on a broader proposal to move marijuana from Schedule I to Schedule III. That hearing is scheduled to begin June 29, 2026. ([justice.gov](https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana))
The action traces back to a December 18, 2025 presidential order directing the Justice Department to speed up medical marijuana and cannabidiol research. DOJ says the April 23 order follows that directive and is meant to give patients, doctors, and researchers clearer rules while keeping federal controls in place. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2025/12/increasing-medical-marijuana-and-cannabidiol-research/))
The immediate effect is limited but real. It does not legalize recreational marijuana under federal law, and it does not finish the broader rescheduling process. DOJ’s own announcement separates the instant Schedule III order for specific medical products from the separate hearing process that will decide whether marijuana should be rescheduled more broadly. ([justice.gov](https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana))
That leaves the administration in the middle of a fight that satisfies almost nobody completely. Drug-war holdouts can read the move as another retreat from the old prohibition model. Cannabis reform supporters get a policy change, but not the full rewrite they have pushed for. For now, the government has narrowed the rule for certain medical products and set up another hearing for the larger question still unresolved. ([justice.gov](https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana))
Comments
Threaded replies, voting, and reports are live. New users still go through screening on their first approved comments.
Log in to comment
No comments yet. Be the first reasonably on-topic person here.